Search

everythinglearnresearchcommunity

for

Search:↓

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Farudodstat can prevent hair follicle immune damage linked to alopecia areata.

Zinc levels and lymphocyte counts might be important in heart disease development.

Regulatory T cells and mesenchymal stem cells work together to prevent immune system overreactions and tissue damage.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

Dendritic epidermal T cells help wounds heal faster by boosting skin stem cell growth.

Long-term fluticasone treatment does not harm the immune system in horses with heaves.

Cyclosporin doesn't stop hair loss.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

CTA is often mistaken for AA but doesn't respond to steroids and may require hair transplantation.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

A sugar glider had a rare skin cancer that worsened despite treatment, highlighting the need for thorough checks in exotic pets.

Laser hair removal doesn't affect thyroid hormones.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.

Experts don't fully agree on how to diagnose certain hair growth disorders and more research is needed to understand them better.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Frontal fibrosing alopecia is linked to hypothyroidism but doesn't affect quality of life.

Metabolic issues may trigger lymphocytic cicatricial alopecia, and treatments targeting these issues could help.

Clinical signs don't match inflammation levels in lichen planopilaris and frontal fibrosing alopecia.

A rare skin rash after COVID-19 vaccination shouldn't stop future vaccinations.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Turkish Van cats' genotypes don't affect traits like eye color or hair length.

Vitamin D receptor gene changes don't affect alopecia areata risk.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

Biotin may help treat inflammatory bowel disease by reducing inflammation and improving gut health.

Hair loss in Cronkhite-Canada syndrome is reversible by treating the gut issues and doesn't need steroid treatment for the hair itself.

A woman with a unique syndrome similar to TRPS has a genetic change near the TRPS1 gene, affecting its regulation.